跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20 条关于
“EAACI”
全部
20
临床试验
2
药物
0
机构
0
资讯
18
去年
Jasper Therapeutics to Present Briquilimab Clinical Data at EAACI Congress 2025
3个月前
Professor Mohamed Shamji Assumes EAACI Presidency as Congress 2026 Concludes with Vision Zero Momentum
2个月前
Yuhan Corporation Presents Phase 1b Results for Novel Anti-IgE Allergy Drug Lesigercept at EAACI 2026
去年
Upstream Bio Presents Data Showing Verekitug's Superior Potency Through TSLP Receptor Targeting at EAACI Congress
3个月前
Stallergenes Greer to Present Paediatric Phase III YOBI Data and Real-World EfficAPSI Findings at EAACI 2026
去年
PRT120 Peanut Oral Immunotherapy Demonstrates Durable 3-Year Remission in Phase 2b Study
2年前
Intellia Therapeutics Reports First Quarter 2024 Financial Results and Operational Progress
2年前
KalVista's Sebetralstat Advances Toward Potential Approval for Hereditary Angioedema
3个月前
Sino Biopharm's TQC2938 Becomes First ST2 Antibody to Show Positive Phase II Results in Allergic Rhinitis
3个月前
Celldex's Bispecific CDX-622 Shows Rapid Mast Cell Depletion and Favorable Safety in First-in-Human Phase 1 Trial
第 1 页,共 2 页
上一页
下一页